Intravacc, a Dutch vaccine R&D institute in Bilthoven the Netherlands and CDBIO, a Chinese Biotech company in Shenyang, China todayannounce that they have signed a research and license agreement to further develop a vaccine against Meningococcal type B based on Intravacc’s proprietary Nonamen® vaccine technology.
Intravacc, a Dutch vaccine R&D institute in Bilthoven the Netherlands and CDBIO, a Chinese Biotech company in Shenyang, China todayannounce that they have signed a research and license agreement to further develop a vaccine against Meningococcal type B based on Intravacc’s proprietary Nonamen® vaccine technology. Both parties will collaborate to tailor the Nonamen® concept for the Chinese market. Following the successful completion of this phase, CDBIO will receive a license to further develop and commercialize the vaccine.
Intravacc’s unique Nonamen® technology offers a broad panel of PorA proteins inserted in so called Outer membrane vesicles (OMV) expected to induce protection against the Meningococcal B (MenB) disease. Furthermore, the Nonamen® technology can be included in a Meningitis combination vaccine.
Under the agreement, both parties will collaborate to establish the development of an efficacious vaccine against prevalent Men B serotypes in China.
“We are very happy to partner with CDBIO and to be able to expand the global reach of our Nonamen technology. We trust this will help to prevent the occurrence of Men B in China considerably”, said Mr Nico Oudendijk, General Director of Intravacc.
About Intravacc: Intravacc, based in Bilthoven, the Netherlands, is an established R&D organization with more than 100 years experience in the development and optimization of vaccines, vaccine processes and vaccine technologies. Intravacc has state-of-the-art research and development facilities and its aim is to contribute to global health and equity in access to vaccines worldwide.
About CDBIO: Liaoning Chengda Biotechnology CO., Ltd, (CDBIO) is a leading company in the area of human vaccines and related products and technologies in the People’s Republic of China
